Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a …

WJ Powers, AA Rabinstein, T Ackerson, OM Adeoye… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations in a single document for clinicians caring for adult …

European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

C Pristipino, H Sievert, F D'ascenzo… - European Heart …, 2019 - academic.oup.com
The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number
of medical conditions; however, the subject remains controversial and no official statements …

Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen ovale after stroke

DM Kent, JL Saver, SE Kasner, J Nelson, JD Carroll… - Jama, 2021 - jamanetwork.com
Importance Patent foramen ovale (PFO)–associated strokes comprise approximately 10% of
ischemic strokes in adults aged 18 to 60 years. While device closure decreases stroke …

Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials

Y Ahmad, JP Howard, AD Arnold… - European Heart …, 2020 - academic.oup.com
Aims The optimal method of revascularization for patients with left main coronary artery
disease (LMCAD) is controversial. Coronary artery bypass graft surgery (CABG) has …

Tailoring the approach to embolic stroke of undetermined source: a review

H Kamel, AE Merkler, C Iadecola, A Gupta… - JAMA …, 2019 - jamanetwork.com
Importance One-third of ischemic strokes have no identifiable cause after standard
evaluation. In 2014, researchers termed theseembolic strokes of undetermined source …

Neurocritical care for extracorporeal membrane oxygenation patients

SM Cho, S Farrokh, G Whitman, TP Bleck… - Critical care …, 2019 - journals.lww.com
Objectives: To review the neurocritical care aspects of patients supported by extracorporeal
membrane oxygenation, including cerebral physiology, neurologic monitoring, use of …

Complete revascularization by percutaneous coronary intervention for patients with ST‐segment–elevation myocardial infarction and multivessel coronary artery …

Y Ahmad, JP Howard, A Arnold, M Prasad… - Journal of the …, 2020 - Am Heart Assoc
Background For patients with ST‐segment–elevation myocardial infarction (STEMI) and
multivessel coronary artery disease, the optimal treatment of the non‐infarct‐related artery …

Patent foramen ovale attributable cryptogenic embolism with thrombophilia has higher risk for recurrence and responds to closure

K Liu, B Song, IF Palacios, I Inglessis-Azuaje… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to investigate the effect of management on the risk for
recurrent events among patients with cryptogenic ischemic stroke or transient ischemic …

Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism

J Wintzer-Wehekind, A Alperi, C Houde, JM Côté… - Journal of the American …, 2019 - jacc.org
Background Patent foramen ovale (PFO) closure is the gold standard for treating patients
with cryptogenic stroke and PFO. However, scarce data exist on the long-term outcomes …

Atrial fibrillation after patent foramen Ovale closure: incidence, pathophysiology, and management

A Apostolos, D Tsiachris, M Drakopoulou… - Journal of the …, 2024 - Am Heart Assoc
This comprehensive review explores the incidence, pathophysiology, and management of
atrial fibrillation (AF) following percutaneous closure of patent foramen ovale (PFO) …